Yeonhee Park
Overview
Explore the profile of Yeonhee Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
327
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Park Y
PLoS One
. 2025 Feb;
20(2):e0318211.
PMID: 39977443
The Mann-Whitney-Wilcoxon test, often referred to as the Mann-Whitney U test or Wilcoxon rank-sum test, is a non-parametric statistical test used to compare two independent groups when the dependent variable...
2.
Yoon J, Kim T, Kim J, Kim H, Lee E, Jung S, et al.
PLoS One
. 2024 Sep;
19(9):e0309902.
PMID: 39325726
Background: Pyrazinamide (PZA) usage has been associated with adverse drug reactions, prompting its avoidance in treating elderly tuberculosis (TB) patients. This study aims to examine whether the administration of PZA...
3.
Park Y, Chang W
Pharm Stat
. 2024 Aug;
23(6):1181-1205.
PMID: 39119879
Dose-finding studies play a crucial role in drug development by identifying the optimal dose(s) for later studies while considering tolerability. This not only saves time and effort in proceeding with...
4.
Lee K, Park Y
Biometrics
. 2024 Jul;
80(3).
PMID: 38949889
The response envelope model proposed by Cook et al. (2010) is an efficient method to estimate the regression coefficient under the context of the multivariate linear regression model. It improves...
5.
Hulahan T, Spruill L, Wallace E, Park Y, West R, Marks J, et al.
Int J Mol Sci
. 2024 Jun;
25(12).
PMID: 38928454
Ductal carcinoma in situ (DCIS) is a heterogeneous breast disease that remains challenging to treat due to its unpredictable progression to invasive breast cancer (IBC). Contemporary literature has become increasingly...
6.
Rujchanarong D, Spruill L, Sandusky G, Park Y, Mehta A, Drake R, et al.
Glycobiology
. 2024 Jun;
34(8).
PMID: 38869882
Higher breast cancer mortality rates continue to disproportionally affect black women (BW) compared to white women (WW). This disparity is largely due to differences in tumor aggressiveness that can be...
7.
Kim K, Kim H, Kim Y, Park Y, Jung S, Kim J, et al.
Respirology
. 2024 Mar;
29(7):624-632.
PMID: 38539055
Background And Objective: Patients with tuberculosis and diabetes have a higher risk of unfavourable anti-tuberculosis treatment outcomes. In the present study, we aimed to evaluate the effects of various diabetes...
8.
Park Y, Lee D, Lee J, Park H, Jung S, Park D, et al.
Cancers (Basel)
. 2024 Feb;
16(3).
PMID: 38339350
The extracellular matrix (ECM) exerts physiological activity, facilitates cell-to-cell communication, promotes cell proliferation and metastasis, and provides mechanical support for tumor cells. The development of solid tumors is often associated...
9.
Park Y, Xu Z
J Biopharm Stat
. 2023 Dec;
35(1):125-144.
PMID: 38131110
The goal of phase II clinical trials is to evaluate the therapeutic efficacy of a new drug. Some investigators want to use the time-to-event endpoint as the primary endpoint of...
10.
Park Y, Chen Y
Contemp Clin Trials Commun
. 2023 Nov;
36:101225.
PMID: 37941851
Clinical trials play a critical role in drug development which involves a series of phases and requires a significant amount of time and effort. Efficient clinical trial designs are necessary...